logo

Tenax Therapeutics Inc (TENX)



Trade TENX now with
  Date
  Headline
8/17/2021 8:06:44 AM Tenax Therapeutics Q2 Net Loss $1.7 Mln Or $0.10/shr Vs Net Loss Of $2.1 Mln Or $0.23/shr Prior Year
8/12/2021 8:04:44 AM Tenax Reports Publication Showing Levosimendan Mechanism Of Action In Pulmonary Hypertension Patients With Heart Failure
7/7/2021 8:05:36 AM Tenax Therapeutics CEO Anthony DiTonno To Retire Effective July 13, 2021
4/9/2021 8:11:32 AM Tenax Therapeutics Announces Publication Of Positive Data From Phase 2 HELP Study
3/2/2021 8:19:08 AM Tenax Therapeutics Appoints Four New Members To Its Board
1/19/2021 7:56:22 AM Tenax Therapeutics Announces Acquisition Of PH Precision Med
11/10/2020 8:36:06 AM Tenax Therapeutics Announces Presentation Of 24-Hour HELP Study Results At AHA Scientific Sessions 2020
8/17/2020 9:32:47 AM Tenax Therapeutics Q2 Net Loss $2.1 Mln Or $0.23/Shr Vs Loss $1.8 Mln Or $0.28/Shr Last Year
7/6/2020 9:03:11 PM Tenax Therapeutics Announces $8.0 Mln Registered Direct And PIPE Offerings
6/3/2020 8:32:18 AM Tenax Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
6/2/2020 7:35:37 AM Tenax Therapeutics Reports Positive Results From Phase 2 Trial Of Levosimendan In Patients With PH-HFpEF
4/9/2020 8:35:29 AM Tenax Therapeutics Announces Last Patient Completes Final Visit In Phase 2 HELP Study Of Levosimendan For PH-HFpEF
3/12/2020 8:33:05 AM Tenax Therapeutics Completes Enrollment In Phase 2 Pulmonary Hypertension Trial